How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension

Rebecca R. Vanderpool; Ankit A. Desai; Shannon M. Knapp; Marc A. Simon; Aiden Abidov; Jason X.J. Yuan; Joe G.N. Garcia; Lillian M. Hansen; Steven R. Knoper; Robert Naeije; Franz P. Rischard

doi:10.1183/13993003.00764-2017

How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension

Rebecca R. Vanderpool, Ankit A. Desai, Shannon M. Knapp, Marc A. Simon, Aiden Abidov, Jason X.J. Yuan, Joe G.N. Garcia, Lillian M. Hansen, Steven R. Knoper, Robert Naeije, Franz P. Rischard

Research output: Contribution to journal › Letter › peer-review

19 Scopus citations

Original language	English (US)
Article number	1700764
Journal	European Respiratory Journal
Volume	50
Issue number	2
DOIs	https://doi.org/10.1183/13993003.00764-2017
State	Published - Aug 1 2017

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1183/13993003.00764-2017

Cite this

How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension. / Vanderpool, Rebecca R.; Desai, Ankit A.; Knapp, Shannon M.; Simon, Marc A.; Abidov, Aiden; Yuan, Jason X.J.; Garcia, Joe G.N.; Hansen, Lillian M.; Knoper, Steven R.; Naeije, Robert; Rischard, Franz P.

In: European Respiratory Journal, Vol. 50, No. 2, 1700764, 01.08.2017.

Research output: Contribution to journal › Letter › peer-review

@article{59bb3f67889f4905a0dab95671ad08a4,

title = "How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension",

author = "Vanderpool, {Rebecca R.} and Desai, {Ankit A.} and Knapp, {Shannon M.} and Simon, {Marc A.} and Aiden Abidov and Yuan, {Jason X.J.} and Garcia, {Joe G.N.} and Hansen, {Lillian M.} and Knoper, {Steven R.} and Robert Naeije and Rischard, {Franz P.}",

note = "Funding Information: Support statement: The initial phase of this study (patients 1–15) was supported in part by United Therapeutics Corp., which did not participate in the design of the study, acquisition of data, analysis, interpretation of the results, or writing of the manuscript. The secondary phase of this study (patients 16–33) was supported in part by the U01 grant HL125208-01 from the National Heart Lung and Blood Institute (PVDOMICS) (F.P. Rischard, A.A. Desai, J.X.-J. Yuan and J.G.N. Garcia). Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: The initial phase of this study (patients 1-15) was supported in part by United Therapeutics Corp., which did not participate in the design of the study, acquisition of data, analysis, interpretation of the results, or writing of the manuscript. The secondary phase of this study (patients 16-33) was supported in part by the U01 grant HL125208-01 from the National Heart Lung and Blood Institute (PVDOMICS) (F.P. Rischard, A.A. Desai, J.X.-J. Yuan and J.G.N. Garcia). Funding information for this article has been deposited with the Crossref Funder Registry.",

year = "2017",

month = aug,

day = "1",

doi = "10.1183/13993003.00764-2017",

language = "English (US)",

volume = "50",

journal = "Scandinavian Journal of Respiratory Diseases",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "2",

}

TY - JOUR

T1 - How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension

AU - Vanderpool, Rebecca R.

AU - Desai, Ankit A.

AU - Knapp, Shannon M.

AU - Simon, Marc A.

AU - Abidov, Aiden

AU - Yuan, Jason X.J.

AU - Garcia, Joe G.N.

AU - Hansen, Lillian M.

AU - Knoper, Steven R.

AU - Naeije, Robert

AU - Rischard, Franz P.

N1 - Funding Information: Support statement: The initial phase of this study (patients 1–15) was supported in part by United Therapeutics Corp., which did not participate in the design of the study, acquisition of data, analysis, interpretation of the results, or writing of the manuscript. The secondary phase of this study (patients 16–33) was supported in part by the U01 grant HL125208-01 from the National Heart Lung and Blood Institute (PVDOMICS) (F.P. Rischard, A.A. Desai, J.X.-J. Yuan and J.G.N. Garcia). Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: The initial phase of this study (patients 1-15) was supported in part by United Therapeutics Corp., which did not participate in the design of the study, acquisition of data, analysis, interpretation of the results, or writing of the manuscript. The secondary phase of this study (patients 16-33) was supported in part by the U01 grant HL125208-01 from the National Heart Lung and Blood Institute (PVDOMICS) (F.P. Rischard, A.A. Desai, J.X.-J. Yuan and J.G.N. Garcia). Funding information for this article has been deposited with the Crossref Funder Registry.

PY - 2017/8/1

Y1 - 2017/8/1

UR - http://www.scopus.com/inward/record.url?scp=85049670203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049670203&partnerID=8YFLogxK

U2 - 10.1183/13993003.00764-2017

DO - 10.1183/13993003.00764-2017

M3 - Letter

C2 - 28838981

AN - SCOPUS:85049670203

VL - 50

JO - Scandinavian Journal of Respiratory Diseases

JF - Scandinavian Journal of Respiratory Diseases

SN - 0903-1936

IS - 2

M1 - 1700764

ER -

How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this